Update to EpiPen Cost Controversy
No sooner than the CEO of the maker of the EpiPen allergy medication aggressively defends the price of the drug, than the company announces that it will have available in just a few weeks a generic version of the drug at half the price. This sudden turnaround raised many to question how this could be accomplished in such a record time given that the Federal Drug Administration (FDA) generally works in years in approving drugs….